Automated quantitative breakdown of fundamental strengths between DRREDDY and SUNPHARMA.
| Financial Metric | DRREDDY | SUNPHARMA |
|---|---|---|
| Valuation Multiples | ||
| Market Capitalization | ₹97,085 Cr | ₹4,41,478 Cr |
| Price to Earnings (P/E) | 30.49 | 36.07 |
| Price to Book (P/B) | 2.72 | 19.73 |
| Profitability & Capital Efficiency | ||
| Return on Capital Employed (ROCE) | 10.39% | 22.11% |
| Return on Equity (ROE) | 21.61% | 12.96% |
| Operating Profit Margin (OPM) | 13.42% | 27.39% |
| Net Profit Margin (NPM) | 2.94% | 12.40% |
| Balance Sheet & Solvency | ||
| Debt to Equity Ratio | 0.22 | 0.61 |
| Dividend Yield | 4.73% | 4.84% |
| Historical Growth | ||
| 3-Year Sales Growth (CAGR) | -18.49% | 11.41% |
| Latest Quarter Financial Results | ||
| Quarterly Revenue (30 Jun 2026) | ₹8,071 Cr | ₹15,184 Cr |
| Quarterly Net Profit | ₹444 Cr | ₹2,895 Cr |
Sun Pharmaceutical Industries vs Cipla Limited
DIVISLAB vs SUNPHARMADivi's Laboratories vs Sun Pharmaceutical Industries
DRREDDY vs CIPLADr. Reddy's Laboratories vs Cipla Limited
LUPIN vs SUNPHARMALupin Limited vs Sun Pharmaceutical Industries
DRREDDY vs LUPINDr. Reddy's Laboratories vs Lupin Limited
MANKIND vs SUNPHARMAMankind Pharma vs Sun Pharmaceutical Industries